| abstract |
The present disclosure provides methods, systems, compositions, and kits to address the need for microbiome-related treatment of health conditions and disease. Specifically, the disclosure provides methods for treatment of metabolic conditions using microbial compositions, the method comprising: administering a therapeutically effective amount of a pharmaceutical composition comprising a population of isolated and purified microbe, wherein at least one of said microbes comprises a microbe that is capable of producing butyrate. |